NWPF

News ArchivesRead News

’Engineered’ Stem Cells May Help Treat Parkinson’s

Thursday December 22, 2005

12/15/05(Forbes) - Engineered human progenitor brain stem cells are able to produce and deliver into the brain a growth factor that shows promise in treating Parkinson’s disease, say researchers at the University of Wisconsin-Madison.

A major challenge in treating Parkinson’s and other neurodegenerative brain disorders is getting drugs to the desired areas of the brain. The brain’s structure effectively blocks the delivery of most drugs via the bloodstream. The engineered progenitor brain cells are designed to sneak drugs past the blood-brain barrier.

The University of Wisconsin team obtained and grew large numbers of progenitor cells from human fetal brain tissue and engineered those cells to produce the growth factor called glial cell line-derived neurotrophic factor (GDNF).

Some small clinical trials showed that GDNF provide relief from the debilitating symptoms of Parkinson’s disease. However, GDNF could not cross the blood-brain barrier and had to be pumped directly into the brains of Parkinson’s patients in order to work.

In this latest study, researchers transplanted the engineered progenitor cells into the brains of rats and monkeys. The cells effectively integrated into the brains of the animals and delivered GDNF to the targeted brain areas.

The findings were published in the Dec. 15 issue of the journal Gene Therapy.

"This work shows that stem cells can be used as drug delivery vehicles in the brain," University of Wisconsin-Madison neuroscientist Clive Svendson said in a prepared statement.

Recent News

Jul 24 - Parkinson's: Mutant gene interaction may pave the way for new treatments
Jul 22 - Boxing training used to fight against Parkinson's disease
Jul 17 - Stem cell treatment breakthrough could cure Parkinson’s patients
Jul 14 - Cancer drug shows early promise for Parkinson's disease
Jul 13 - Opinion: Dividing the Caregiving Responsibilities Between Siblings
Jul 12 - Researchers make advance in possible treatments for Gaucher, Parkinson’s diseases
Jul 11 - Parkinson’s Head Trauma Link Looks Even Stronger
Jul 7 - Penn students’ start-up XEED puts wearables to work against Parkinson’s disease
Jul 5 - Last Patient Enrolled in Pivotal Phase 3 Parkinson’s Disease Trial, Cynapsus Therapeutics Says
Jun 29 - Exoskeleton Could Quell the Tremors of Parkinson's Disease Patients at Crucial Moments
Jun 28 - Parkinson's disease: New protein discovery could fuel new treatments
Jun 27 - Study finds direct evidence linking Parkinson’s to autoimmune disease; 2 genes that are key regulators of immune system discovered
Jun 27 - Blocking key enzyme halts parkinson's disease symptoms in mice
Jun 23 - Parkinson's Research Might Benefit from Novel Discovery of Zinc Transport Protein Structure
Jun 23 - Parkinson's disease breakthrough 'could lead to cure'
Jun 20 - More American men diagnosed with Parkinson's
Jun 15 - First monkey genetically engineered to have Parkinson’s created
Jun 14 - Fighting Parkinson's in the lab
Jun 9 - A New Gene Has Been Linked to Parkinson's Disease
Jun 6 - A neurologist weighs in on Muhammad Ali's battle with Parkinson's disease